Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

General

Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors

Yoon-Koo Kang, Min-Hee Ryu, Yong Sang Hong, Chang-Min Choi, Tae Won Kim, Baek-Yeol Ryoo, Jeong Eun Kim, John R. Weis, Rachel Kingsford, Cheol Hee Park, Seong Jang, Arlo McGinn, Theresa L. Werner, Sunil Sharma

Cancer Res Treat. 2024;56(3):743-750. Published online January 18, 2024 DOI: https://doi.org/10.4143/crt.2023.980

Clinical Characteristics and Continued Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Administration in EGFR-mutated Non-Small Cell Lung Cancer with Skeletal Metastasis

Sook-Hee Hong, Yeon-Sil Kim, Ji Eun Lee, In-ho Kim, Seung Joon Kim, Daehee Han, Ie Ryung Yoo, Yang-Guk Chung, Young-Hoon Kim, Kyo-Young Lee, Jin-Hyoung Kang

Cancer Res Treat. 2016;48(3):1110-1119. Published online January 6, 2016 DOI: https://doi.org/10.4143/crt.2015.289

Web of Science 7 Crossref 7

Endoscopic Criteria for Evaluating Tumor Stage after Preoperative Chemoradiation Therapy in Locally Advanced Rectal Cancer

Kyung Su Han, Dae Kyung Sohn, Dae Yong Kim, Byung Chang Kim, Chang Won Hong, Hee Jin Chang, Sun Young Kim, Ji Yeon Baek, Sung Chan Park, Min Ju Kim, Jae Hwan Oh

Cancer Res Treat. 2016;48(2):567-573. Published online September 22, 2015 DOI: https://doi.org/10.4143/crt.2015.195

Web of Science 8 Crossref 7

Therapeutic Implication of Intracavitary Instillation of Interferon-alpha-2b in Advanced Solid Tumors

Yeul Hong Kim

J Korean Cancer Assoc. 1994;26(3):510-519.

Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410 FAX: +82-2-792-1410 E-mail: journal@cancer.or.kr

About | Browse Articles | Current Issue | For Authors and Reviewers